Develops drugs for autoimmune diseases.
Sep 2015Revenue $0.00/yrExpenses $2.73M/yr
No trend
Figures by year
When will Biomolecular Life Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Sep 2015, revenue was $0.00 and expenses $2.73M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2014 | $0.00 | $4.14M | −$4.14M |
| Dec 2013 | $0.00 | $3.91M | −$3.91M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.